XML 36 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
12 Months Ended
Feb. 12, 2016
Dec. 31, 2017
Dec. 31, 2016
Cash equivalents, at carrying value  
Payments to acquire marketable securities   3,431,414
Proceeds from sale of marketable securities   2,145,000
Marketable securities, gross realized (gain) loss   766
Marketable securities, gross unrealized gain (loss)   (1,427)
Marketable securities   $ 1,285,753  
Marketable securities maturity dates   January 4, 2018 to February 22, 2018  
Goodwill, impairment loss   $ 404,169
Fair value assumptions, expected dividend rate 0.00% 0.00% 0.00%
Derivative, gain (loss) on derivative, net   $ (91,032) $ 29,445
Private Placement [Member] | Series B Preferred Stock [Member] | Placement Agent Warrants [Member]      
Class of warrant or right, issued 127,346    
Private Placement [Member] | Series B Preferred Stock [Member] | Debt Settlement [Member] | Strategic Bio Partners [Member]      
Class of warrant or right, issued 295,945    
Equipment [Member]      
Property, plant and equipment, useful life   3 years